Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Ceftaroline Fosamil
2. Ppi-0903
3. Ppi0903
4. Tak-599
5. Tak599
6. Teflaro
1. Tak-599
2. Schembl1464044
3. Gtpl10899
4. Q409712
5. (6r,7r)-7-((z)-2-(ethoxyimino)-2-(5-(phosphonoamino)-1,2,4-thiadiazol-3-yl)acetamido)-3-((4-(1-methylpyridin-1-ium-4-yl)thiazol-2-yl)thio)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
Molecular Weight | 684.7 g/mol |
---|---|
Molecular Formula | C22H21N8O8PS4 |
XLogP3 | 2.3 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 17 |
Rotatable Bond Count | 10 |
Exact Mass | 684.01028135 g/mol |
Monoisotopic Mass | 684.01028135 g/mol |
Topological Polar Surface Area | 330 Ų |
Heavy Atom Count | 43 |
Formal Charge | 0 |
Complexity | 1210 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
J01DI02
S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
100
PharmaCompass offers a list of Ceftaroline Fosamil API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ceftaroline Fosamil manufacturer or Ceftaroline Fosamil supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ceftaroline Fosamil manufacturer or Ceftaroline Fosamil supplier.
PharmaCompass also assists you with knowing the Ceftaroline Fosamil API Price utilized in the formulation of products. Ceftaroline Fosamil API Price is not always fixed or binding as the Ceftaroline Fosamil Price is obtained through a variety of data sources. The Ceftaroline Fosamil Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ceftaroline Fosamil manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ceftaroline Fosamil, including repackagers and relabelers. The FDA regulates Ceftaroline Fosamil manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ceftaroline Fosamil API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ceftaroline Fosamil manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ceftaroline Fosamil supplier is an individual or a company that provides Ceftaroline Fosamil active pharmaceutical ingredient (API) or Ceftaroline Fosamil finished formulations upon request. The Ceftaroline Fosamil suppliers may include Ceftaroline Fosamil API manufacturers, exporters, distributors and traders.
click here to find a list of Ceftaroline Fosamil suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ceftaroline Fosamil DMF (Drug Master File) is a document detailing the whole manufacturing process of Ceftaroline Fosamil active pharmaceutical ingredient (API) in detail. Different forms of Ceftaroline Fosamil DMFs exist exist since differing nations have different regulations, such as Ceftaroline Fosamil USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Ceftaroline Fosamil DMF submitted to regulatory agencies in the US is known as a USDMF. Ceftaroline Fosamil USDMF includes data on Ceftaroline Fosamil's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ceftaroline Fosamil USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Ceftaroline Fosamil suppliers with USDMF on PharmaCompass.
Ceftaroline Fosamil Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ceftaroline Fosamil GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ceftaroline Fosamil GMP manufacturer or Ceftaroline Fosamil GMP API supplier for your needs.
A Ceftaroline Fosamil CoA (Certificate of Analysis) is a formal document that attests to Ceftaroline Fosamil's compliance with Ceftaroline Fosamil specifications and serves as a tool for batch-level quality control.
Ceftaroline Fosamil CoA mostly includes findings from lab analyses of a specific batch. For each Ceftaroline Fosamil CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ceftaroline Fosamil may be tested according to a variety of international standards, such as European Pharmacopoeia (Ceftaroline Fosamil EP), Ceftaroline Fosamil JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ceftaroline Fosamil USP).